CARTaGENE

The CARTaGENE (CaG) study is both a population-based biobank and the largest ongoing prospective health study of men and women in Quebec. CaG targeted the segment of the population that is most at risk of developing chronic disorders, that is 40-69 years of age, from six census metropolitan areas in Quebec. The sampling was stratified by age, sex and postal groups and is proportional to the density of the population in these areas. Over 43,000 participants consented to visiting 1 of 12 assessment sites where detailed health and socio-demographic information, physiological measures and biological samples (blood, serum and urine) were captured. Participants are followed-up based on linkage to governmental health administrative databases and direct reassessment through a web portal.

Last update 21/09/2017

Types General population-based cohort
Participant Types No diagnosis
Countries Canada
Genders Male and Female
Sample sizes 20,000 to 49,999
Ages 40 to 59|60 to 100
Brain related measures Cognitive function|Mental health|Neurological
Funtional rating
Anthropometric Blood pressure|Height|Hip circumference|Waist circumference|Weight
Physical Cardiovascular|Hearing and Vision|Musculoskeletal|Reproductive|Respiratory
Biological samples Blood|Saliva|Urine
Genotyping Gene screening
Brain imaging Magnetic resonance imaging (MRI)
Brain banking
Lifestyle Alcohol|Dietary habits|Physical activity|Smoking
Socio-economic Education|Ethnic group|Family circumstances|Housing and accommodation|Income and finances|Informal support|Marital status|Occupation and employment|Unpaid care
Health service utilisation Formal health and social care service utilisation including private care
Institute names CHU Sainte-Justine Research Centre
Current Sample Sizes 20,000 to 49,999

age at recruitment 40-69
last updated
recruitment period 2009-2013|2013-2015
estimated current sample size number value 43000
cohort acronym CaG
start date 2009-2013|2013-2015
pi Dr Anne-Monique Nuyt and Dr Sebastien Jacquemont
website http://www.cartagene.qc.ca/en/home
contact details CHU Sainte-Justine Research Centre
3333 Queen-Mary, Office 490/493
Montreal
H3V 1A2
Qc, CA
abstract  The CAG study is the largest prospective health study in Quebec. Over 43,000 participants over 40-69 were recruited between 2009-2010.
funders  Genome Quebec, CPAC
contact email Email: [email protected] PI emails: [email protected] and [email protected]
contact phone number Tel: 514-343-7703 ext. 6393
estimated current sample size 20,000 to 49,999
sample sizes 43000